Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax

Table 1

Baseline demographic characteristics of the patients enrolled in the study.

PQ regimens	Group A; (no PQ)	Group B; (15 mg/day × 14 days)	Group C; (30 mg/day × 7 days)	Group D; (30 mg/day × 14 days)
Number of patients enrolled	397	398	381	380
Total drop outs	92 (23.1%)	76 (19%)	83 (21.7%)	63 (16.5%)
Number of patients who completed 6 months of followup	305	322	298	317
Age in years; (mean ± SD)	18–76 (30 ± 14)	18–76 (31 ± 12)	18–74 (32 ± 13)	18–70 (32 ± 11)
Gender
Male	374	378	364	365
Female	23	20	17	15
Parasitemia	120–16780/L	160–17600/L	175–15620/L	105–19239/L